Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aveanna Healthcare HoldingsAVAH +3.18%62 Debt-to-EBITDA is 4.65 as of Mar. 2026, which is 42% below its 10-year median of 8.02. GuruFocus rates AVAH with a GF Score™ of 62/100 and a GF Value™ of $5.18 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Aveanna Healthcare Holdings ranks worse than 75.31% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Aveanna Healthcare Holdings's Debt-to-EBITDA or its related term are showing as below:
AVAH'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -79 Med: 8.02 Max: 38.28
Current: 4.98
During the past 8 years, the highest Debt-to-EBITDA Ratio of Aveanna Healthcare Holdings was 38.28. The lowest was -79.00. And the median was 8.02.
AVAH's Debt-to-EBITDA is ranked worse than 75.31% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs AVAH: 4.98
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Aveanna Healthcare Holdings Debt-to-EBITDA Related Terms
Aveanna Healthcare Holdings Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVAH vs SNDA, ADUS, AGL: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aveanna Healthcare Holdings Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aveanna Healthcare Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Aveanna Healthcare Holdings (AVAH) has a Debt-to-EBITDA of 4.65 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Aveanna Healthcare Holdings. This is 42% below median its historical median of 8.02. According to the industry distribution chart, Aveanna Healthcare Holdings ranks #360 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 75.3%.
Is Aveanna Healthcare Holdings' Debt-to-EBITDA too high?
Aveanna Healthcare Holdings' current Debt-to-EBITDA of 4.65 is 42% below median its 10-year median of 8.02. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Aveanna Healthcare Holdings' value of 4.65 is 106.7% above this industry median. Based on the distribution chart, Aveanna Healthcare Holdings ranks #360 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aveanna Healthcare Holdings has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aveanna Healthcare Holdings' Debt-to-EBITDA compare to SNDA and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Aveanna Healthcare Holdings ranks #360 out of 478 companies for Debt-to-EBITDA. This places Aveanna Healthcare Holdings in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. Aveanna Healthcare Holdings' value of 4.65 is 106.7% above this benchmark. While the company's 10-year median is 8.02 vs. the industry median of 2.25, Aveanna Healthcare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aveanna Healthcare Holdings's current Debt-to-EBITDA of 4.65 is 106.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Aveanna Healthcare Holdings. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aveanna Healthcare Holdings's current Debt-to-EBITDA is 4.65, which is 42% below median its own 10-year median of 8.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aveanna Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings (AVAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.18, compared to a current price of $9.90 — trading 91.1% above its estimated fair value. The current Debt-to-EBITDA is 4.65, which is 42% below median its 10-year median of 8.02 and 106.7% above the Healthcare Providers & Services industry median of 2.25. Aveanna Healthcare Holdings' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Aveanna Healthcare Holdings (AVAH), the current Debt-to-EBITDA is 4.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aveanna Healthcare Holdings (AVAH) Overvalued in 2026?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings stock appears to be overvalued.
The current stock price of $9.90 is trading 91.1% above its estimated GF Value™ of $5.18.
GuruFocus considers Aveanna Healthcare Holdings to be Significantly Overvalued.
Key valuation signals for AVAH:
Debt-to-EBITDA: 4.65 (42% below median its 10-year median of 8.02)
GF Value™: $5.18 vs. price of $9.90 (91.1% above fair value)
Industry Position: 106.7% above the Healthcare Providers & Services median (#360 of 478)
No single metric tells the full story. See the AVAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
62GF Score
Get the complete analysis for AVAH
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAH has been successfully added to your 
